Truist Financial Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Announces Target Price $65

Futu News10:31 · Ratings

Truist Financial Remains a Buy on Bristol-Myers Squibb (BMY)

TipRanks09:16 · Ratings

Bristol Late-stage Trial of Opdivo for Head and Neck Cancer Meets Endpoint

Seeking AlphaJan 7 21:43

Express News | Refile-Buzz-Obesity Drugs, M&a Among Key Pharma Drivers for 2025, Berenberg Says

BreakingsJan 7 21:22

Should Bristol-Myers Squibb Company (NYSE:BMY) Be In Your Early Retirement Portfolio?

Yahoo FinanceJan 7 19:52

Bristol-Myers Squibb (NYSE:BMY) Has A Pretty Healthy Balance Sheet

Yahoo FinanceJan 7 19:01